Nanobiotechnology Market By Technology (Bio-nanomaterials, Nanoparticles, Nanocrystals, Quantum dots, Liposomes, Polymer Structures Dendrimers, Nanopores, and Integrated Nanostructures), By Service Provider (Drug Delivery, Sequencing, Biologic Imaging, Research Tools, and Microbicide) – Growth, Share, Opportunities & Competitive Analysis, 2016 – 2023

Price: $4999

Published: | Report ID: 14350 | Report Format : PDF

Market Insights

This report on the nanobiotechnology market studies various technologies and applications. Nanobiotechnology deals with biological and biochemical applications. Nanobiotechnology mostly studies existing elements of living organisms and nature to fabricate new nanodevices. The potential uses and benefits of nanotechnology are vast.

The major applications of nanobiotechnology exist in the biomedical field. They are primarily targeted toward developing novel drug delivery systems, which are expected to remain the major application of nanobiotechnology throughout the forecast period.

For this study, the global nanobiotechnology market is segmented based on technology type into nanoparticles, nanocrystals, quantum dots, liposomes, polymer structures (dendrimers), nanopores, and integrated nanostructures. Market size estimates and forecasts for these segments for 2013–2023 are provided in terms of USD million, along with the respective compounded annual growth rates (CAGRs) for 2016–2023, considering 2015 as the base year.

The nanobiotechnology market is segmented based on application type: drug delivery, sequencing, biologic imaging, research tools, and microbicide. Market size estimates and forecasts for these segments for 2013–2023 are provided in terms of USD million, along with the respective compounded annual growth rates (CAGRs) for 2016–2023, considering 2015 as the base year.

The nanobiotechnology market has been geographically categorized into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, Brazil, and the GCC countries. The market size and forecast for these segments during 2013–2023 and their CAGRs for the period 2016–2023 are provided in this report.

The major key players profiled in the nanobiotechnology market are based on characteristics such as business description, financial health, budget allocation, product portfolio, and news coverage. The key players profiled in this report are Aduro BioTech, Calando Pharmaceuticals Inc., Baxter International, Inc., Fresenius Kabi AG, Smith & Nephew plc, Biosante Phosphate Pharmaceuticals Inc., Celgene Corporation, Elan Pharmaceuticals Inc., Flamel Technologies Inc., Nanophase Technologies Corporation, Sigma Aldrich Company, Dendritic Nanotechnologies Inc., and SkyePharma Pharmaceuticals.

Based on the type of application, the global nanobiotechnology market is segmented as follows:

  • Drug Delivery
  • Sequencing
  • Biologic Imaging
  • Research Tools
  • Microbicide

On the basis of application, the nanobiotechnology market is segmented into drug delivery, sequencing, biological imaging, research tools, and microbicide. In 2015, drug delivery and sequencing segments were observed as the largest segments of nanobiotechnology, accounting for a market share of around 55%. Biotechnology and pharmaceutical industries are expected to remain the largest end-users of Nanobiotechnology.

Market experts suggested that drug delivery is the most crucial pharmaceutical application and that nanobiotechnology is now the most focused area in this field. In drug delivery applications, apart from solving solubility issues of the drug, it also helps enhance intracellular delivery possibilities and the level of skin permeability in transdermal drug delivery. Thus, nanobiotechnology possesses the potential to develop breakthrough interface systems that allow interaction between novel electronic devices and biological systems.

Based on the type of technology, the nanobiotechnology market is segmented into:

  • Bio-nanomaterials
  • Nanoparticles
  • Nanocrystals
  • Quantum dots
  • Liposomes
  • Polymer Structures: Dendrimers
  • Nanopores
  • Integrated Nanostructures

In 2015, the segments liposomes and polymer-structured dendrimers collectively accounted for the major market share of around 50%. They were expected to maintain their dominance throughout the forecast period. The rising prevalence of cancer, increasing public awareness related to novel treatments for cancer, and constant technological upgradation in the field of nanotechnology research and development.

The major restraints on this market, especially in emerging and underdeveloped economies, are scarcity of resources and mounting technological costs. However, rising pharmaceutical demand is expected to open up novel growth opportunities within the forecast period. Market experts suggest that nanobiotechnology also possesses the capability to develop breakthrough interface systems between physical objects and living cells to allow interaction between modern electronic devices and biological systems. The decades of in-depth research and development in nanobiotechnology are now assisting access to novel avenues of healthcare, such as the synthesis of advanced nanofabricated systems and devices for treating several untreatable diseases.

For this study, the global nanobiotechnology market is categorized into three segments:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

In the base year of 2015, North America accounted for the largest share of the global nanobiotechnology market, followed by Europe, Asia-Pacific, LATAM, and MEA. However, the Asia-Pacific region (comprising Japan, China, and India as major countries) is anticipated to grow at the fastest CAGR during the forecast period of 2016–202. The key factors assisting the growth of the nanobiotechnology market in North America and Europe are the rising prevalence of cancer, the high acceptance rate of novel modes of treatment, the high accessibility to advanced healthcare infrastructure, and a favorable environment for nanobiotechnology–based research and development.

Asia-Pacific was observed as the fastest-growing region throughout the forecast period of 2016–2023 due to rising public awareness related to cancer diagnosis and treatment, developing healthcare services and research and development infrastructure, and high market penetration and acceptance of novel treatment technologies. The major restraints on this market, especially in emerging and underdeveloped economies, are scarcity of resources and mounting technological costs. However, rising pharmaceutical demand is expected to open up novel growth opportunities within the forecast period.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Nanobiotechnology Market, by Technology Type, 2015 v/s 2023 (Value %)
2.2 Global Nanobiotechnology Market, by Application Type, 2015 (USD Mn)
2.3 Global Nanobiotechnology Market, by Geography, 2015 (Value %)

Chapter 3 Global Nanobiotechnology Market Overview
3.1 Overview
3.2 Market Drivers
3.3 Market Restraints
3.4 Market Opportunities
3.5 Attractive Investment Proposition
3.6 Market Competition Assessment: Nanobiotechnology Market, by Key Players

Chapter 4 Global Nanobiotechnology Market Analysis, By Technology Type
4.1 Overview
4.2 Bio-nanomaterials
4.3 Nanoparticles
4.4 Nanocrystals
4.5 Quantum dots
4.6 Liposomes
4.7 Polymer Structures Dendrimers
4.8 Nanopores
4.9 Integrated Nanostructures

Chapter 5 Global Nanobiotechnology Market Analysis, By Applications
5.1 Overview
5.2 Drug Delivery
5.3 Sequencing
5.4 Biologic Imaging
5.5 Research Tools
5.6 Microbicide

Chapter 6 Global Nanobiotechnology Market Analysis, By Geography
6.1 Preface
6.2 North America
6.3 Europe
6.4 Asia Pacific
6.5 Latin America
6.6 Middle East and Africa

Chapter 7 Company Profiles
7.1 Aduro BioTech
7.1.1 Aduro BioTech: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.2 Calando Pharmaceuticals Inc.
7.2.1 Calando Pharmaceuticals Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.3 Baxter International, Inc.
7.3.1 Baxter International, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.4 Fresinuns Kabi AG
7.4.1 Fresinuns Kabi AG: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.5 Smith & Nephew plc
7.5.1 Smith & Nephew plc: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.6 Biosante Phosphate Pharmaceuticals Inc.
7.6.1 Biosante Phosphate Pharmaceuticals Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.7 Celgene Corporation
7.7.1 Celgene Corporation: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.8 Elan Pharmaceuticals Inc.
7.8.1 Elan Pharmaceuticals Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.9 Flamel Technologies Inc.
7.9.1 Flamel Technologies Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.10 Nanophase Technologies Corporation
7.10.1 Nanophase Technologies Corporation: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.11 Sigma Aldrich Company
7.11.1 Sigma Aldrich Company: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.12 Dendritic Nanotechnologies Inc.
7.12.1 Dendritic Nanotechnologies Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.13 SkyePharma Pharmaceuticals
7.13.1 SkyePharma Pharmaceuticals: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)

List of Figures

FIG. 1 Nanobiotechnology Market: Research Methodology
FIG. 2 Global Nanobiotechnology Market, by Technology Type, 2015 v/s 2023 (Value %)
FIG. 3 Global Nanobiotechnology Market, by Application Type, 2015 (USD Mn)
FIG. 4 Global Nanobiotechnology Market, by Geography, 2015 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography, 2015
FIG. 6 Bio-nanomaterials Technology Market in Nanobiotechnology, 2013 – 2023 (USD Mn)
FIG. 7 Nanoparticles Technology Market in Nanobiotechnology, 2013 – 2023 (USD Mn)
FIG. 8 Nanocrystals Technology Market in Nanobiotechnology, 2013 – 2023 (USD Mn)
FIG. 9 Quantum dots Technology Market in Nanobiotechnology, 2013 – 2023 (USD Mn)
FIG. 10 Liposomes Technology Market in Nanobiotechnology, 2013 – 2023 (USD Mn)
FIG. 11 Polymer Structures Dendrimers Technology Market in Nanobiotechnology, 2013 – 2023 (USD Mn)
FIG. 12 Nanopores Technology Market in Nanobiotechnology, 2013 – 2023 (USD Mn)
FIG. 13 Integrated Nanostructures Technology Market in Nanobiotechnology, 2013 – 2023 (USD Mn)
FIG. 14 Nanobiotechnology Application Market in Drug Delivery, 2013 – 2023 (USD Mn)
FIG. 15 Nanobiotechnology Application Market in Sequencing, 2013 – 2023 (USD Mn)
FIG. 16 Nanobiotechnology Application Market in Biologic Imaging, 2013 – 2023 (USD Mn)
FIG. 17 Nanobiotechnology Application Market in Research Tools, 2013 – 2023 (USD Mn)
FIG. 18 Nanobiotechnology Application Market in Microbicide, 2013 – 2023 (USD Mn)
FIG. 19 North America Nanobiotechnology Market , 2013 – 2023 (USD Mn)
FIG. 20 Europe Nanobiotechnology Market , 2013 – 2023 (USD Mn)
FIG. 21 Asia-Pacific Nanobiotechnology Market , 2013 – 2023 (USD Mn)
FIG. 22 Latin America Nanobiotechnology Market , 2013 – 2023 (USD Mn)
FIG. 23 Middle East and Africa Nanobiotechnology Market , 2013 – 2023 (USD Mn)

List of Tables

TABLE 1 Market Competition Assessment: Nanobiotechnology , by Key Players
TABLE 2 Global Nanobiotechnology Market, by Technology Type, 2013-2023 (USD Mn)
TABLE 3 Global Nanobiotechnology Market, by Applications, 2013-2023 (USD Mn)
TABLE 4 Global Nanobiotechnology Market, by Geography, 2013 – 2023 (USD Mn)
TABLE 5 Aduro BioTech: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 6 Calando Pharmaceuticals Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 7 Baxter International, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 8 Fresinuns Kabi AG: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 9 Smith & Nephew plc: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 10 Biosante Phosphate Pharmaceuticals Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 11 Celgene Corporation: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 12 Elan Pharmaceuticals Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 13 Flamel Technologies Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 14 Nanophase Technologies Corporation: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 15 Sigma Aldrich Company: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 16 Dendritic Nanotechnologies Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 17 SkyePharma Pharmaceuticals: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)

Frequently Asked Questions:

What is the size of Nanobiotechnology Market?

The market for Nanobiotechnology Market is expected to reach USD 46,870.5 Mn By 2023.

What is the Nanobiotechnology Market CAGR?

The Nanobiotechnology Market is expected to see significant CAGR growth over the coming years, at 8.7%.

What is the Forecast period considered for Nanobiotechnology Market?

The report is forecasted from 2016 To 2023.

What is the base year considered for Nanobiotechnology Market?

The base year of this report is 2015.

Who are the major players in this market?

Aduro BioTech, Calando Pharmaceuticals Inc., Baxter International, Inc., Fresenius Kabi AG, Smith & Nephew plc, Biosante Phosphate Pharmaceuticals Inc., Celgene Corporation, are some of the major players in the global market.

Smart Grid Managed Services Market

Published:
Report ID: 10208

Picture Archiving and Communication Systems (PACS) Market

Published:
Report ID: 9676

Chatbots Market

Published:
Report ID: 3733

Over-the-Top (OTT) Market

Published:
Report ID: 8377

Enterprise Video Market

Published:
Report ID: 5414

Enterprise Video Conferencing Market

Published:
Report ID: 5393

Conditional Access System (CAS) Market

Published:
Report ID: 4145

Internet Protocol Television (IPTV) Market

Published:
Report ID: 7037

Non-Volatile Memory Market

Published:
Report ID: 34142

Automotive Fuse Market

Published:
Report ID: 34095

Wireless Fetal Monitoring System Market

Published:
Report ID: 33986

Action Cameras Market

Published:
Report ID: 1277

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN